1. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
2. ChamberlainSR et al. Royal College of Psychiatrists’ Psychopharmacology Committee. Position statement on the use of monoamine oxidase inhibitors in psychiatric practice (PS03/20).July 2020. Available from:https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps03_20.pdf?sfvrsn=bc814c70_2
3. Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis
4. Biochemistry and pharmacology of reversible inhibitors of MAO‐A agents: focus on moclobemide;Nair NP;J Psychiatry Neurosci,1993
5. CG91. 2009 National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: recognition and management